The National Healthcare Security Administration (NHSA) will unveil the results of the negotiation and price bidding for the National Reimbursement Drug List (NRDL) adjustment at a press conference scheduled for 10:00 am on November 28th. This event marks a significant moment in the healthcare sector as it will disclose the outcomes of the process that concluded on October 30.
Significant Number of Generic Drugs in NRDL Negotiation/Price Bidding
A total of 162 generic name drugs were part of the negotiation and price bidding process, which included 117 drugs that were previously not on the NRDL and 45 that were already listed. The inclusion of such a large number of generic drugs highlights the government’s efforts to expand patient access to affordable medications and to optimize the drug reimbursement system.-Fineline Info & Tech
Leave a Reply